Skip to main content

Advertisement

SpringerLink
Log in

Expression analysis of mTOR-associated lncRNAs in multiple sclerosis

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

mTOR has been shown to be involved in the regulation of immune responses and differentiation of immune cells. This protein is a candidate molecule for unraveling the molecular mechanisms of autoimmune disorders such as multiple sclerosis (MS). We designed the current study to assess expression of MTOR, and four associated long non-coding RNAs (lncRNAs), namely SNHG1, SNHG3, SHNG5 and DANCR in the peripheral blood of patients with MS compared with healthy controls. Analysis of real-time PCR results has shown down-regulation of SNHG5 and DANCR in MS patients compared with controls. Sex of study participants had no significant effect on expression of either genes and the interaction of sex and disease on expression levels of all studied genes were insignificant. There was a significant negative correlation between expression levels of MTOR gene and disease duration. No other significant correlations were detected between genes expressions and clinical/demographic data. SNHG5 and DANCR transcript levels had AUC values of 0.88 and 0.68 in separation of patients with MS from healthy controls, respectively. Taken together, our study suggests participation of two mTOR-related lncRNAs, i.e. SNHG5 and DANCR in the pathophysiology of MS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  • Amiri M, Mokhtari MJ, Bayat M, Safari A, Dianatpuor M, Tabrizi R, Borhani-Haghighi A (2022) Expression and diagnostic values of MIAT, H19, and NRON long non-coding RNAs in multiple sclerosis patients. Egypt J Med Hum Genet 23:1–9

    Article  Google Scholar 

  • Chapman NM, Chi H (2014) mTOR signaling, Tregs and immune modulation. Immunotherapy 6:1295–1311

    Article  CAS  Google Scholar 

  • Giacoppo S, Pollastro F, Grassi G, Bramanti P, Mazzon E (2017) Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis. Fitoterapia 116:77–84

    Article  CAS  Google Scholar 

  • Han W, Shi J, Cao J, Dong B, Guan W (2020) Latest Advances of Long Non-Coding RNA SNHG5 in Human Cancers. Onco Targets Ther 13:6393–6403

    Article  CAS  Google Scholar 

  • Hermida MA, Kumar JD, Leslie NR (2017) GSK3 and its interactions with the PI3K/AKT/mTOR signalling network. Adv Biol Regul 65:5–15

    Article  CAS  Google Scholar 

  • Jhanwar-Uniyal M, Amin AG, Cooper JB, Das K, Schmidt MH, Murali R (2017) Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects. Adv Biol Regul 64:39–48

    Article  CAS  Google Scholar 

  • Kim M, Jo H, Kwon Y, Jeong MS, Jung HS, Kim Y, Jeoung D (2021) MiR-154-5p-MCP1 Axis Regulates Allergic Inflammation by Mediating Cellular Interactions. Front Immunol 12:2080

    Google Scholar 

  • Li C, Han T, Li R, Fu L, Yue L (2020) miR-26a-5p mediates TLR signaling pathway by targeting CTGF in LPS-induced alveolar macrophage. Biosci Rep 40:BSR20192598

    Article  CAS  Google Scholar 

  • Liu Y, Zhang D-T, Liu X-G (2015) mTOR signaling in T cell immunity and autoimmunity. Int Rev Immunol 34:50–66

    Article  Google Scholar 

  • Lu QC, Rui ZH, Guo ZL, Xie W, Shan S, Ren T (2018) LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression. J Cell Mol Med 22:1527–1537

    Article  CAS  Google Scholar 

  • Mammana S, Bramanti P, Mazzon E, Cavalli E, Basile MS, Fagone P, Petralia MC, Mccubrey JA, Nicoletti F, Mangano K (2018) Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis. Oncotarget 9:8263–8277

    Article  Google Scholar 

  • Meydan C, Madrer N, Soreq H (2020) The neat dance of COVID-19: NEAT1, DANCR, and co-modulated cholinergic RNAs link to inflammation. Front Immunol 11:590870

    Article  CAS  Google Scholar 

  • Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302

    Article  Google Scholar 

  • Safa A, Arsang-Jang S, Taheri M, Omrani MD, Ghafouri-Fard S (2021) Dysregulation of NF-κB-Associated lncRNAs in multiple sclerosis patients. J Mol Neurosci 71:80–88

    Article  CAS  Google Scholar 

  • Sun I-H, Oh M-H, Zhao L, Patel CH, Arwood ML, Xu W, Tam AJ, Blosser RL, Wen J, Powell JD (2018) mTOR Complex 1 Signaling Regulates the Generation and Function of Central and Effector Foxp3(+) Regulatory T Cells. J Immunol (Baltimore, Md. : 1950) 201:481–492

    Article  CAS  Google Scholar 

  • Taherian-Esfahani Z, Taheri M, Dashti S, Kholghi-Oskooei V, Geranpayeh L, Ghafouri-Fard S (2019) Assessment of the expression pattern of mTOR-associated lncRNAs and their genomic variants in the patients with breast cancer. J Cell Physiol 234:22044–22056

    Article  CAS  Google Scholar 

  • Tong X, Gu P-C, Xu S-Z, Lin X-J (2015) Long non-coding RNA-DANCR in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. Biosci Biotechnol Biochem 79:732–737

    Article  CAS  Google Scholar 

  • Zhang S, Lin S, Tang Q, Yan Z (2021) Knockdown of miR-205-5p alleviates the inflammatory response in allergic rhinitis by targeting B-cell lymphoma 6. Mol Med Rep 24:1–11

    Google Scholar 

Download references

Acknowledgements

This study was financially supported by Grant from Medical School of Shahid Beheshti University of Medical Sciences.

Author information

Authors and Affiliations

  1. Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Mohammadarian Akbari

  2. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Fatemeh Eshghyar

  3. Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Mahdi Gholipour, Mir Davood Omrani & Soudeh Ghafouri-Fard

  4. Department of Medical Biotechnology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

    Solat Eslami

  5. Dietary Supplements and Probiotic Research Center, Alborz University of Medical Sciences, Karaj, Iran

    Solat Eslami

  6. Department of Pharmacognosy, College of Pharmacy, Hawler Medical University, Kurdistan Region, Erbil, Iraq

    Bashdar Mahmud Hussen

  7. Center of Research and Strategic Studies, Lebanese French University, Erbil, Kurdistan Region, Iraq

    Bashdar Mahmud Hussen

  8. Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Mohammad Taheri

  9. Institute of Human Genetics, Jena University Hospital, Jena, Germany

    Mohammad Taheri

Authors
  1. Mohammadarian Akbari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fatemeh Eshghyar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahdi Gholipour
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Solat Eslami
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bashdar Mahmud Hussen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mohammad Taheri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mir Davood Omrani
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Soudeh Ghafouri-Fard
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SGF wrote the manuscript and revised it. MDO and MT supervised and designed the study. MG, MA, BMH and FE performed the experiment. SE analyzed the data. All authors read and approved the submitted version.

Corresponding authors

Correspondence to Mohammad Taheri, Mir Davood Omrani or Soudeh Ghafouri-Fard.

Ethics declarations

Ethics approval and consent to Participant

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent forms were obtained from all study participants. The study protocol was approved by the ethical committee of Shahid Beheshti University of Medical Sciences. All methods were performed in accordance with the relevant guidelines and regulations.

Consent of publication

Not applicable.

Competing Interest

The authors declare they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Akbari, M., Eshghyar, F., Gholipour, M. et al. Expression analysis of mTOR-associated lncRNAs in multiple sclerosis. Metab Brain Dis 37, 2061–2066 (2022). https://doi.org/10.1007/s11011-022-01010-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-022-01010-8

Keywords

Search

Navigation